Portal de investigação
The Association of Leptin with Left Ventricular Hypertrophy in End-Stage Kidney Disease Patients on Dialysis
Data de publicação:
Autores da FMUP
Participantes de fora da FMUP
- Coimbra, S
- Catarino, C
- Faria, MS
- Rocha, S
- Valente, MJ
- Rocha Pereira, P
- Bronze-da-Rocha, E
- Beco, A
- Marques, SHD
- Madureira, A.
- Fernandes, JC
- Miranda, V
- Belo, L
- Santos Silva, A.
Unidades de investigação
Abstract
Left ventricular hypertrophy (LVH) is a common cardiovascular complication in end-stage kidney disease (ESKD) patients. We aimed at studying the association of LVH with adiponectin and leptin levels, cardiovascular stress/injury biomarkers and nutritional status in these patients. We evaluated the LV mass (LVM) and calculated the LVM index (LVMI) in 196 ESKD patients on dialysis; the levels of hemoglobin, calcium, phosphorus, parathyroid hormone, albumin, adiponectin, leptin, N-terminal pro B-type natriuretic peptide (NT-proBNP) and growth differentiation factor (GDF)-15 were analyzed. ESKD patients with LVH (n = 131) presented higher NT-proBNP and GDF-15, lower hemoglobin and, after adjustment for gender, lower leptin levels compared with non-LVH patients. LVH females also showed lower leptin than the non-LVH female group. In the LVH group, LVMI presented a negative correlation with leptin and a positive correlation with NT-proBNP. Leptin emerged as an independent determinant of LVMI in both groups, and NT-proBNP in the LVH group. Low hemoglobin and leptin and increased calcium, NT-proBNP and dialysis vintage are associated with an increased risk of developing LVH. In ESKD patients on dialysis, LVH is associated with lower leptin values (especially in women), which are negatively correlated with LVMI, and with higher levels of biomarkers of myocardial stress/injury. Leptin and NT-proBNP appear as independent determinants of LVMI; dialysis vintage, hemoglobin, calcium, NT-proBNP and leptin emerged as predicting markers for LVH development. Further studies are needed to better understand the role of leptin in LVH in ESKD patients.
Dados da publicação
- ISSN/ISSNe:
- 2227-9059, 2227-9059
- Tipo:
- Article
- Páginas:
- 1026-
- Link para outro recurso:
- www.scopus.com
Biomedicines MDPI AG
Citações Recebidas na Scopus: 1
Documentos
- Não há documentos
Filiações
Keywords
- leptin; left ventricular mass index; NT-proBNP; hemoglobin; calcium; GDF-15
Financiamento
Proyectos asociados
Cardiac rehabilitation in the elderly: novel challenges for a time-tested intervention
Investigador Principal: José Pedro Lopes Nunes
Estudo Clínico Académico . 2021
Corticosteróides e a COVID-19
Investigador Principal: José Pedro Lopes Nunes
Estudo Clínico Académico . 2021
Cintigrafia de Perfusão Miocárdica no Enfarte do Miocárdio: Impacto da elevação do segmento ST e da Diabetes mellitus
Investigador Principal: José Pedro Lopes Nunes
Estudo Clínico Académico . 2021
Left Ventricular Reverse Remodeling and Function by Strain Analysis in Aortic Stenosis
Investigador Principal: Nuno Teodoro V. Reis Bettencourt Sousa
Estudo Clínico Académico . 2020
Sobre Alguns Factores Que Influenciam Os Efeitos Da Terapêutica Com Aspirina Em Doentes Com Acidente Vascular Cerebral Isquémico
Investigador Principal: José Pedro Lopes Nunes
Estudo Clínico Académico . 2022
Epicardial adipose Tissue, Coronary Artery Disease and Cardiac Remodeling in High-risk Patients: EPICHEART Study
Investigador Principal: Nuno Teodoro V. Reis Bettencourt Sousa
Estudo Clínico Académico . 2019
Citar a publicação
Coimbra S,Catarino C,Faria MS,Nunes J,Rocha S,Valente MJ,Rocha P,Bronze E,Bettencourt N,Beco A,Marques SHD,Oliveira J,Madureira A,Fernandes JC,Miranda V,Belo L,Santos A. The Association of Leptin with Left Ventricular Hypertrophy in End-Stage Kidney Disease Patients on Dialysis. Biomedicines. 2023. 11. (4):p. 1026-1026. IF:4,700. (1).
